11,376 Shares in Select Medical Holdings Co. (NYSE:SEM) Acquired by Counterpoint Mutual Funds LLC

Counterpoint Mutual Funds LLC bought a new position in Select Medical Holdings Co. (NYSE:SEM) in the fourth quarter, HoldingsChannel reports. The fund bought 11,376 shares of the health services provider’s stock, valued at approximately $214,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Quarry LP purchased a new stake in Select Medical in the 3rd quarter worth approximately $30,000. Smartleaf Asset Management LLC lifted its position in Select Medical by 179.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider’s stock worth $43,000 after buying an additional 1,473 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in Select Medical in the 3rd quarter worth approximately $81,000. Virtu Financial LLC purchased a new stake in Select Medical in the 3rd quarter worth approximately $210,000. Finally, Quantbot Technologies LP purchased a new stake in Select Medical in the 3rd quarter worth approximately $232,000. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Stock Performance

Shares of SEM opened at $16.89 on Wednesday. The company has a market capitalization of $2.18 billion, a PE ratio of 10.23, a price-to-earnings-growth ratio of 0.64 and a beta of 1.56. Select Medical Holdings Co. has a one year low of $16.20 and a one year high of $40.98. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The company’s fifty day moving average price is $18.70 and its 200 day moving average price is $25.95.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, February 20th. The health services provider reported $0.18 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.11). The firm had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.50 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. As a group, analysts expect that Select Medical Holdings Co. will post 1.17 earnings per share for the current year.

Select Medical Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, March 13th. Investors of record on Monday, March 3rd were issued a $0.0625 dividend. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.25 annualized dividend and a yield of 1.48%. Select Medical’s dividend payout ratio (DPR) is presently 15.15%.

Analysts Set New Price Targets

SEM has been the subject of a number of research analyst reports. UBS Group cut their target price on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. Benchmark upgraded shares of Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a report on Monday, February 24th. StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a report on Friday, February 21st. Finally, Royal Bank of Canada cut their price target on shares of Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a report on Monday, February 24th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $27.25.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.